Dimerization of Tie2 mediated by its membrane-proximal FNIII domains
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Significance: Tie2 is a receptor tyrosine kinase with important roles in vascular development. Inhibiting Tie2 may impair tumor angiogenesis, whereas activating Tie2 may be beneficial in sepsis and inflammation. To modulate Tie2 therapeutically, it is essential to understand its regulation. Although it is known how Tie2 binds its activating ligands (angiopoietins), it is not clear how this binding (or Tie1 interactions) regulates the receptor. Here, we show that the previously unstudied Tie2 extracellular membrane-proximal region engages in receptor–receptor contacts crucial for Tie2 activation. Our data suggest that angiopoietins promote receptor clustering, utilizing Tie2–Tie2 interactions mediated by key fibronectin III domains, a unique mode of RTK activation. Blocking these Tie2–Tie2 interactions may have therapeutic value in cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, the model of the dimeric ANGPT2147–496 in complex with the inactive, half-bent α5β1-integrin and TIE2 ECDs could be created without steric clashes while maintaining the overall geometry and interactions of the existing structures found in this study and previously (13, 16, 54–56) (Figure 8, A and B, and Supplemental Video 2).”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [54]
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Self-citationDali server: conservation mapping in 3D
Holm, L., & Rosenstr�m, P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq366 · Cited by 3,640
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570 · cited 1×
“Similarly, although Ang2 can activate Tie2 expressed in NIH 3T3 cells, this ligand instead functions as an antagonist or partial agonist in endothelial cells and in vivo (9, 16, 17).”
BackgroundSvergun, D., Barberato, C., & Koch, M. H. J. (1995) · Journal of Applied Crystallography · doi:10.1107/s0021889895007047 · Cited by 3,434
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
DAMMIF , a program for rapid ab-initio shape determination in small-angle scattering
Franke, D., & Svergun, D. I. (2009) · Journal of Applied Crystallography · doi:10.1107/s0021889809000338 · Cited by 2,021
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989 · cited 1×
“T Tie family [named as “tyrosine kinases with immunoglobulin and EGF homology domains” (1)] of receptor tyrosine kinases (RTKs) contains two members, Tie1 and Tie2/ TEK, that are expressed primarily on endothelial cells and control cellular responses to the angiopoietin (Ang) ligands (2, 3).”
BackgroundControl of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465 · cited 2×
“Tie1 and Tie2 play important roles in the development of normal vasculature, in vascular homeostasis, and in angiogenesis (4, 5).”
BackgroundAutomated matching of high- and low-resolution structural models
Kozin, M. B., & Svergun, D. I. (2001) · Journal of Applied Crystallography · doi:10.1107/s0021889800014126 · Cited by 1,302
Lemke, G. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009076 · Cited by 598 · cited 1×
“It will be interesting to determine whether the analogous FNIII domains in the Tyro/Axl/Mer family (43) have similar self-association functions.”
BackgroundAngiopoietins 3 and 4: Diverging gene counterparts in mice and humans
Valenzuela, D. M., Griffiths, J. A., Rojas, J., Aldrich, T. H., Jones, P. F., Zhou, H., McClain, J., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1904 · Cited by 472
Saharinen, P., Eklund, L., Miettinen, J., Wirkkala, R., Anisimov, A., Winderlich, M., Nottebaum, A., Vestweber, D., Deutsch, U., Koh, G. Y., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1715 · Cited by 471 · cited 1×
“These stark signaling differences appear to arise, at least in part, from the altered subcellular location of Tie2 and/or from differences in Tie2 (or Tie1/Tie2) clustering or oligomerization following engagement by Angs in different cellular contexts (18, 19).”
BackgroundTargeting the ANGPT–TIE2 pathway in malignancy
Huang, H., Bhat, A., Woodnutt, G., & Lappe, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2894 · Cited by 468 · cited 2×
“Tie receptor signaling therefore has emerged as an attractive target for therapeutic intervention in tumor angiogenesis, inflammation, and sepsis (6, 7).”
BackgroundFukuhara, S., Sako, K., Minami, T., Noda, K., Kim, H. Z., Kodama, T., Shibuya, M., Takakura, N., Koh, G. Y., & Mochizuki, N. (2008) · Nature Cell Biology · doi:10.1038/ncb1714 · Cited by 387 · cited 1×
“These stark signaling differences appear to arise, at least in part, from the altered subcellular location of Tie2 and/or from differences in Tie2 (or Tie1/Tie2) clustering or oligomerization following engagement by Angs in different cellular contexts (18, 19).”
BackgroundAngiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium
Yuan, H. T., Khankin, E. V., Karumanchi, S. A., & Parikh, S. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01472-08 · Cited by 373 · cited 1×
“Similarly, although Ang2 can activate Tie2 expressed in NIH 3T3 cells, this ligand instead functions as an antagonist or partial agonist in endothelial cells and in vivo (9, 16, 17).”
BackgroundPartanen, J., Armstrong, E., Mäkelä, T. P., Korhonen, J., Sandberg, M., Renkonen, R., Knuutila, S., Huebner, K., & Alitalo, K. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1698 · Cited by 373 · cited 1×
“T Tie family [named as “tyrosine kinases with immunoglobulin and EGF homology domains” (1)] of receptor tyrosine kinases (RTKs) contains two members, Tie1 and Tie2/ TEK, that are expressed primarily on endothelial cells and control cellular responses to the angiopoietin (Ang) ligands (2, 3).”
BackgroundStructural Basis for Activation of the Receptor Tyrosine Kinase KIT by Stem Cell Factor
Yuzawa, S., Opatowsky, Y., Zhang, Z., Mandiyan, V., Lax, I., & Schlessinger, J. (2007) · Cell · doi:10.1016/j.cell.2007.05.055 · Cited by 359 · cited 8×
“Moreover, targeting these membrane-proximal interactions to inhibit Tie2 activity, as seen for other RTKs (24, 25), may have therapeutic value.”
BackgroundInfluentialStructure and distribution of modules in extracellular proteins
Bork, P., Downing, A. K., Kieffer, B., & Campbell, I. D. (1996) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500005783 · Cited by 324
Tie1 controls angiopoietin function in vascular remodeling and inflammation
Korhonen, E. A., Lampinen, A., Giri, H., Anisimov, A., Kim, M., Allen, B., Fang, S., D’Amico, G., Sipilä, T. J., Lohela, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84923 · Cited by 283 · cited 3×
“Ang binding does not induce conformational alterations in the Tie2 LBR, indicating that Tie2 oligomerization and signaling are most likely specified by Ang multimerization (14) and/or by Tie1 interactions (12, 15, 16), with the Tie2 extracellular region (ECR) playing a passive role.”
BackgroundAngiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity
Souma, T., Tompson, S. W., Thomson, B. R., Siggs, O. M., Kizhatil, K., Yamaguchi, S., Feng, L., Limviphuvadh, V., Whisenhunt, K. N., Maurer-Stroh, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85830 · Cited by 259 · cited 3×
“A Y611C mutation was recently reported as a Tie2 loss-of-function mutation in primary congenital glaucoma (23) and was found to impair Ang1-induced Tie2 phosphorylation, further implicating the dimer 1 interface in Tie2 activation in vivo.”
BackgroundInfluentialOpposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation
Kim, M., Allen, B., Korhonen, E. A., Nitschké, M., Yang, H. W., Baluk, P., Saharinen, P., Alitalo, K., Daly, C., Thurston, G., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84871 · Cited by 243 · cited 2×
“Ang binding does not induce conformational alterations in the Tie2 LBR, indicating that Tie2 oligomerization and signaling are most likely specified by Ang multimerization (14) and/or by Tie1 interactions (12, 15, 16), with the Tie2 extracellular region (ECR) playing a passive role.”
BackgroundDavis, S., Papadopoulos, N., Aldrich, T. H., Maisonpierre, P. C., Huang, T., Kovac, L., Xu, A., Leidich, R., Radziejewska, E., Rafique, A., et al. (2003) · Nature Structural Biology · doi:10.1038/nsb880 · Cited by 234
Saharinen, P., Kerkelä, K., Ekman, N., Marron, M., Brindle, N., Lee, G. M., Augustin, H., Koh, G. Y., & Alitalo, K. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200411105 · Cited by 233 · cited 1×
“There is a substantial literature on the influence of Tie1 on Tie2 signaling (5, 15, 30, 37) and on direct interactions between the two receptors (12, 38), which might involve FNIII domain contacts of the sort described here.”
BackgroundAn extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly
Seiradake, E., Harlos, K., Sutton, G., Aricescu, A. R., & Jones, E. Y. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1782 · Cited by 222 · cited 2×
“A similar role for membrane-proximal FNIII domains in RTK clustering has been suggested in Eph receptor clustering, where multiple interfaces in the ECR of the receptor are required for localization and signaling (33, 34).”
BackgroundInteraction between proteins localized in membranes.
Grasberger, B., Minton, A. P., DeLisi, C., & Metzger, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6258 · Cited by 215 · cited 2×
“48 μM for sTie2 dimerization, strong enough to drive dimerization of at least half of the intact Tie2 in the membrane of a cell with 10,000 copies (27).”
BackgroundHow IGF-1 activates its receptor
Kavran, J. M., McCabe, J. M., Byrne, P. O., Connacher, M. K., Wang, Z., Ramek, A., Sarabipour, S., Shan, Y., Shaw, D. E., Hristova, K., et al. (2014) · eLife · doi:10.7554/elife.03772 · Cited by 186
Tie1-Tie2 Interactions Mediate Functional Differences between Angiopoietin Ligands
Seegar, T. C. M., Eller, B., Tzvetkova-Robev, D., Kolev, M. V., Henderson, S. C., Nikolov, D. B., & Barton, W. A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.007 · Cited by 183 · cited 8×
“Structural studies have shown how Angs bind to the Tie2 ligand-binding region, but do not explain Tie2 activation and suggest a passive role for the Tie2 extracellular region (ECR) in ligand-induced receptor dimerization.”
BackgroundInfluentialReceptor Tyrosine Kinase-Mediated Angiogenesis
Jeltsch, M., Leppanen, V.-M., Saharinen, P., & Alitalo, K. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009183 · Cited by 175
Savant, S., La Porta, S., Budnik, A., Busch, K., Hu, J., Tisch, N., Korn, C., Valls, A. F., Benest, A. V., Terhardt, D., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.024 · Cited by 173 · cited 1×
“There is a substantial literature on the influence of Tie1 on Tie2 signaling (5, 15, 30, 37) and on direct interactions between the two receptors (12, 38), which might involve FNIII domain contacts of the sort described here.”
BackgroundOligomerization and Multimerization Are Critical for Angiopoietin-1 to Bind and Phosphorylate Tie2
Kim, K.-T., Choi, H.-H., Steinmetz, M. O., Maco, B., Kammerer, R. A., Ahn, S. Y., Kim, H.-Z., Lee, G. M., & Koh, G. Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500292200 · Cited by 170 · cited 1×
“The clustering model, together with the requirement for oligomeric ligands (14, 41), suggests similarities with the extended signaling arrays of Eph family receptors thought to be “seeded” by extracellular interactions (33, 34, 42).”
BackgroundTvorogov, D., Anisimov, A., Zheng, W., Leppänen, V., Tammela, T., Laurinavičius, S., Holnthoner, W., Heloterä, H., Holopainen, T., Jeltsch, M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.001 · Cited by 157 · cited 8×
“Moreover, targeting these membrane-proximal interactions to inhibit Tie2 activity, as seen for other RTKs (24, 25), may have therapeutic value.”
BackgroundInfluentialBogdanovic, E., Nguyen, V. P. K. H., & Dumont, D. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03077 · Cited by 153 · cited 1×
“Sorted cells were expanded, serum starved, and stimulated with antibody-clustered Ang1 as described (28).”
MethodCrystal structures of the Tie2 receptor ectodomain and the angiopoietin-2–Tie2 complex
Barton, W. A., Tzvetkova-Robev, D., Miranda, E. P., Kolev, M. V., Rajashankar, K. R., Himanen, J. P., & Nikolov, D. B. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1101 · Cited by 134 · cited 2×
“Both bury more than 1,000 Å(2) of surface area in the dimer interface, comparable to the 1,300 Å(2) buried when Ang1 binds to Tie2 (20).”
BackgroundStructural basis of Tie2 activation and Tie2/Tie1 heterodimerization
Leppänen, V.-M., Saharinen, P., & Alitalo, K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616166114 · Cited by 127 · cited 12×
“Freely available online through the PNAS open access option.”
BackgroundInfluentialStructure of a Tyrosine Phosphatase Adhesive Interaction Reveals a Spacer-Clamp Mechanism
Aricescu, A. R., Siebold, C., Choudhuri, K., Chang, V. T., Lu, W., Davis, S. J., van der Merwe, P. A., & Jones, E. Y. (2007) · Science · doi:10.1126/science.1144646 · Cited by 110
Structurally encoded intraclass differences in EphA clusters drive distinct cell responses
Seiradake, E., Schaupp, A., del Toro Ruiz, D., Kaufmann, R., Mitakidis, N., Harlos, K., Aricescu, A. R., Klein, R., & Jones, E. Y. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2617 · Cited by 107 · cited 1×
“The clustering model, together with the requirement for oligomeric ligands (14, 41), suggests similarities with the extended signaling arrays of Eph family receptors thought to be “seeded” by extracellular interactions (33, 34, 42).”
BackgroundBarton, W. A., Tzvetkova‐Robev, D., & Nikolov, D. B. (2005) · Structure · doi:10.1016/j.str.2005.03.009 · Cited by 92 · cited 2×
“By contrast, protein lacking all three FNIII domains failed to selfassociate even at 10 μM (26), and protein lacking the two most C-terminal FNIII domains crystallized as a monomer (21).”
BackgroundAngiopoietin-4 Promotes Glioblastoma Progression by Enhancing Tumor Cell Viability and Angiogenesis
Brunckhorst, M. K., Wang, H., Lu, R., & Yu, Q. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4125 · Cited by 75
Xu, K. Y., Tzvetkova‐Robev, D., Xu, Y., Goldgur, Y., Chan, Y., Himanen, J. P., & Nikolov, D. B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311000110 · Cited by 74 · cited 2×
“A similar role for membrane-proximal FNIII domains in RTK clustering has been suggested in Eph receptor clustering, where multiple interfaces in the ECR of the receptor are required for localization and signaling (33, 34).”
BackgroundStructural basis for angiopoietin-1–mediated signaling initiation
Yu, X., Seegar, T. C. M., Dalton, A. C., Tzvetkova-Robev, D., Goldgur, Y., Rajashankar, K. R., Nikolov, D. B., & Barton, W. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216890110 · Cited by 69 · cited 7×
“It also should be noted that, compared with the low-resolution structure of FNIIIa in Protein Data Bank (PDB) entry 4K0V (21), we see a shift in register by two residues, beginning around residue 486 in the loop between strands C and C′.”
BackgroundMethodInfluentialMacdonald, P. R., Progias, P., Ciani, B., Patel, S., Mayer, U., Steinmetz, M. O., & Kammerer, R. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605219200 · Cited by 59 · cited 1×
“These models are also consistent with lollipop-like Tie2 ECR structures seen by rotary shadowing electron microscopy (32).”
ResultStructural Analysis of Sensor Domains from the TMAO-Responsive Histidine Kinase Receptor TorS
Moore, J. O., & Hendrickson, W. A. (2009) · Structure · doi:10.1016/j.str.2009.07.015 · Cited by 57
Self-citationLoughna, S., & Sato, T. N. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00171-x · Cited by 52 · cited 1×
“T Tie family [named as “tyrosine kinases with immunoglobulin and EGF homology domains” (1)] of receptor tyrosine kinases (RTKs) contains two members, Tie1 and Tie2/ TEK, that are expressed primarily on endothelial cells and control cellular responses to the angiopoietin (Ang) ligands (2, 3).”
BackgroundLigand regulation of a constitutively dimeric EGF receptor
Freed, D. M., Alvarado, D., & Lemmon, M. A. (2015) · Nature Communications · doi:10.1038/ncomms8380 · Cited by 42 · cited 2×
“activate the receptor, possibly in a manner influenced by Tie1, further distinguishes Tie2 from RTKs such as the insulin receptor (39) and Caenorhabditis elegans LET-23 (40), which have dimeric ECRs.”
BackgroundInfluentialSelf-citationTie2 and Eph Receptor Tyrosine Kinase Activation and Signaling
Barton, W. A., Dalton, A. C., Seegar, T. C. M., Himanen, J. P., & Nikolov, D. B. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009142 · Cited by 37 · cited 3×
“for Tie2 clustering in cells (14, 30), suggests that both dimers might form simultaneously to yield higher-order receptor oligomers.”
BackgroundReshetnyak, A. V., Nelson, B., Shi, X., Boggon, T. J., Pavlenco, A., Mandel-Bausch, E. M., Tomé, F., Suzuki, Y., Sidhu, S. S., Lax, I., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317118110 · Cited by 33 · cited 10×
“Moreover, targeting these membrane-proximal interactions to inhibit Tie2 activity, as seen for other RTKs (24, 25), may have therapeutic value.”
BackgroundInfluentialOligomerized Tie2 localizes to clathrin-coated pits in response to angiopoietin-1
Bogdanovic, E., Coombs, N. A., & Dumont, D. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-009-0603-3 · Cited by 25 · cited 1×
“Consistent with this suggestion, immunogold electron microscopy (35) and bimolecular fluorescence complementation (BiFC) assays (36) have argued that Tie2 forms ligand-independent dimers in the membranes of both endothelial cells and HEK-293 cells.”
BackgroundTargeting Tie2 and the host vascular response in sepsis
Parikh, S. M. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf5537 · Cited by 23 · cited 1×
“Tie receptor signaling therefore has emerged as an attractive target for therapeutic intervention in tumor angiogenesis, inflammation, and sepsis (6, 7).”
BackgroundLigand-independent Tie2 Dimers Mediate Kinase Activity Stimulated by High Dose Angiopoietin-1
Yamakawa, D., Kidoya, H., Sakimoto, S., Jia, W., Naito, H., & Takakura, N. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.433979 · Cited by 15 · cited 1×
“Consistent with this suggestion, immunogold electron microscopy (35) and bimolecular fluorescence complementation (BiFC) assays (36) have argued that Tie2 forms ligand-independent dimers in the membranes of both endothelial cells and HEK-293 cells.”
Background
Cited by
Therapeutic targeting of the angiopoietin–TIE pathway
Saharinen, P., Eklund, L., & Alitalo, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.278 · Cited by 620
Angiopoietin-1 is required for Schlemm’s canal development in mice and humans
Thomson, B. R., Souma, T., Tompson, S. W., Onay, T., Kizhatil, K., Siggs, O. M., Feng, L., Whisenhunt, K. N., Yanovitch, T. L., Kalaydjieva, L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95545 · Cited by 171
Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP
Souma, T., Thomson, B. R., Heinen, S., Anna Carota, I., Yamaguchi, S., Onay, T., Liu, P., Ghosh, A. K., Li, C., Eremina, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714446115 · Cited by 135
“Higher oligomerization status is required to cluster the TIE2 receptors in cis and elicit downstream signaling cascades due to the relatively large “physical” distance between them, as characterized by the wide angular conformational structure on cell membrane (39, 48).”
BackgroundStructural basis of Tie2 activation and Tie2/Tie1 heterodimerization
Leppänen, V.-M., Saharinen, P., & Alitalo, K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616166114 · Cited by 127
“Freely available online through the PNAS open access option.”
BackgroundMethodInfluentialLAG3 ectodomain structure reveals functional interfaces for ligand and antibody recognition
Ming, Q., Celias, D. P., Wu, C., Cole, A. R., Singh, S., Mason, C. C., Dong, S., Tran, T. H., Amarasinghe, G. K., Ruffell, B., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01238-7 · Cited by 99
Metadata
- Authors
- Moore, J. O., Lemmon, M. A., & Ferguson, K. M.
- Affiliations
- University of Pennsylvania (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-04-10
- Volume
- 114
- Issue
- 17
- Pages
- 4382-4387
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5410832
- OpenAlex
- W2606533043
- Cited by
- 30
- References
- 49
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 7 · 2020: 4 · 2019: 3 · 2018: 3 · 2017: 4
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- HHS | NIH | National Cancer Institute (R03-CA187021)
- HHS | NIH | National Institute of General Medical Sciences (R01-GM099891, R01-GM107435)
- American Cancer Society (123704-PF-13-034-01-DMC)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- Tie2, receptor dimerization, fibronectin type III domain, angiopoietin-1, receptor activation, Tie1, receptor tyrosine kinase, angiogenesis, tumor angiogenesis, receptor oligomerization, crystal structure
- MeSH terms
- Protein Domains, Animals, Cell Membrane, Humans, Models, Molecular, Mutation, Protein Conformation, X-Ray Diffraction, NIH 3T3 Cells, Receptor, TIE-2, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.